Generic Ivacaftor is One Step Closer in the US
If you’ve followed my blog for the last year or so, you’ve seen that I’ve been repeatedly...
Read MorePosted by Gunnar Esiason | Jul 12, 2022 | Health Policy, Today in Medicine |
If you’ve followed my blog for the last year or so, you’ve seen that I’ve been repeatedly...
Read MorePosted by Gunnar Esiason | Jun 13, 2022 | Business School, In My Experience |
I blinked and it was over. It was three years, two degrees, a marriage, and a baby. My time in...
Read MorePosted by Gunnar Esiason | Apr 20, 2022 | Today in Medicine |
With news of the emerging biotech company, Sionna, coming out of stealth yesterday, there is, once...
Read MorePosted by Gunnar Esiason | Apr 7, 2022 | Today in Medicine |
Gene therapies are all the rage these days in the world of emerging biotech. It’s not hard to...
Read MorePosted by Gunnar Esiason | Mar 21, 2022 | In My Experience |
It’s been a little while since I last blogged – I guess I should have expected that after the baby...
Read More*Nothing contained in these blog posts, podcasts, images, or any other posts should be considered medical advice. Such advice can only be given by a physician who is experienced with cystic fibrosis. The contributors on this blog/podcast cannot be held responsible for any damage which may result from using the information on this blog/podcast without permission of their medical doctor. Furthermore, the views expressed on this blog are solely those of the contributors and do not represent the views or opinions of the writer’s employer(s) unless explicitly mentioned.